Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



Living with Dementia

neuropathology of ad1 - risk of alzheimer's3 - dotage1 - vascular risk factors2 - memory decline2 - risperidone2 - cognitive deficits1 - functional activation studies1 - myelination1 - hormone replacement therapy1 - moderate parkinson's disease1 - impassable plaques1 - prichard1 - preventing alzheimer's1 - psychometrics1 - sobrino1 - smile study1 - amyloid plaques13 - confabulation1 - apraxia3 - autosomal dominant gene mutation1 - neurodegeneration2 - physical weakness1 - cvd1 - tau3 - cognitive functioning2 - mental confusion4 - pet1 - enlarged ventricles1 - interviews by magistrates1 -